Insider Trading activities at Plus Therapeutics, Inc. (PSTV)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Plus Therapeutics, Inc. (PSTV) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Plus Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1095981.

Total stock buying since 2015: $894,205.
Total stock sales since 2015: $1,135,091.
Total stock option exercises since 2015: $0.


16 insiders reported insider trading activities at Plus Therapeutics, Inc. (PSTV):
Insider trading activities of Postfinance Ag
Insider trading activities of Lenk Robert P
Insider trading activities of Sims Andrew John Hugh Macintyre
Insider trading activities of Kesten Steven
Insider trading activities of Thompson Tommy G
Insider trading activities of Hawkins Richard J
Insider trading activities of Rickey David
Insider trading activities of Harris John David
Insider trading activities of Girao Tiago
Insider trading activities of Hayden Jeremy B.
Insider trading activities of Hedrick Marc H
Insider trading activities of Clowes Howard
Insider trading activities of Lim Kian Thiam
Insider trading activities of Swissquote Bank Sa
Insider trading activities of Naughton Gail K
Insider trading activities of Petersen Greg

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Plus Therapeutics, Inc. (PSTV).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 110,000 $53,790 0 $0 0 $0
2024 184,738 $348,604 0 $0 0 $0
2023 55,088 $97,360 0 $0 0 $0
2022 65,000 $39,420 4,500 $1,416 0 $0
2021 36,913 $70,702 0 $0 0 $0
2020 36,700 $91,167 0 $0 0 $0
2018 0 $0 898,412 $311,075 0 $0
2016 158,500 $46,024 0 $0 0 $0
2015 409,849 $147,138 600,000 $822,600 0 $0

Table 2. Monthly summary of insider trading at Plus Therapeutics, Inc. (PSTV).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 110,000 $53,790 0 $0 0 $0
2024-09 39,883 $53,104 0 $0 0 $0
2024-05 144,855 $295,500 0 $0 0 $0
2023-11 24,594 $39,198 0 $0 0 $0
2023-09 26,993 $44,080 0 $0 0 $0
2023-06 1,000 $3,980 0 $0 0 $0
2023-05 2,500 $9,102 0 $0 0 $0
2023-03 1 $1,000 0 $0 0 $0
2022-12 0 $0 4,500 $1,416 0 $0
2022-06 20,000 $11,835 0 $0 0 $0
2022-05 30,000 $16,500 0 $0 0 $0
2022-04 13,000 $8,885 0 $0 0 $0
2022-03 2,000 $2,200 0 $0 0 $0
2021-11 1,000 $1,864 0 $0 0 $0
2021-10 17,000 $28,988 0 $0 0 $0
2021-09 7,000 $13,013 0 $0 0 $0
2021-07 4,230 $8,357 0 $0 0 $0
2021-04 2,183 $4,970 0 $0 0 $0
2021-03 5,500 $13,510 0 $0 0 $0
2020-12 2,500 $4,975 0 $0 0 $0
2020-11 2,200 $4,708 0 $0 0 $0
2020-08 27,000 $70,984 0 $0 0 $0
2020-06 5,000 $10,500 0 $0 0 $0
2018-02 0 $0 709,986 $242,079 0 $0

Table 3. Detailed insider trading at Plus Therapeutics, Inc. (PSTV)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-22 Lenk Robert P Buy 110,000 .49 53,790
2024-09-13 Hawkins Richard J Buy 4,000 1.50 5,996
2024-09-12 Hawkins Richard J Buy 6,285 1.35 8,509
2024-09-11 Clowes Howard Buy 5,000 1.34 6,680
2024-09-11 Petersen Greg Buy 12,500 1.35 16,875
2024-09-10 Sims Andrew John Hugh Macintyre (Chief Financial Officer) Buy 4,098 1.27 5,204
2024-09-10 Hedrick Marc H (Chief Executive Officer) Buy 8,000 1.23 9,840
2024-05-08 Clowes Howard Buy 19,608 2.04 40,000
2024-05-08 Sims Andrew John Hugh Macintyre (Chief Financial Officer) Buy 9,804 2.04 20,000
2024-05-08 Petersen Greg Buy 24,510 2.04 50,000
2024-05-08 Lenk Robert P Buy 8,334 2.04 17,000
2024-05-08 Hawkins Richard J Buy 9,804 2.04 20,000
2024-05-08 Hedrick Marc H (Chief Executive Officer) Buy 24,510 2.04 50,000
2023-11-16 Lenk Robert P (Director) Buy 1,000 1.95 1,950
2023-11-15 Lenk Robert P (Director) Buy 1,000 1.77 1,770
2023-11-13 Lenk Robert P (Director) Buy 4,000 1.43 5,720
2023-11-10 Lenk Robert P (Director) Buy 2,000 1.45 2,900
2023-11-09 Lenk Robert P (Director) Buy 4,199 1.59 6,676
2023-11-08 Lenk Robert P (Director) Buy 5,000 1.65 8,250
2023-11-07 Lenk Robert P (Director) Buy 6,000 1.64 9,840
2023-11-06 Lenk Robert P (Director) Buy 1,395 1.50 2,092
2023-09-13 Clowes Howard (Director) Buy 6,993 1.43 10,020
2023-09-11 Petersen Greg (Director) Buy 20,000 1.70 34,060
2023-06-06 Clowes Howard (Director) Buy 1,000 3.98 3,980
2023-05-03 Clowes Howard (Director) Buy 2,500 3.64 9,102
2023-03-03 Hawkins Richard J (Director) Buy 1 1,000.00 1,000
2022-12-30 Lenk Robert P (Director) Sale 3,000 .32 944
2022-06-15 Hedrick Marc H (Chief Executive Officer) Buy 5,000 .65 3,240
2022-06-02 Clowes Howard (Director) Buy 15,000 .57 8,595
2022-05-17 Petersen Greg (Director) Buy 30,000 .55 16,500
2022-04-26 Sims Andrew John Hugh Macintyre (Chief Financial Officer) Buy 3,000 .67 2,016
2022-04-26 Hedrick Marc H (Chief Executive Officer) Buy 7,500 .69 5,159
2022-03-01 Sims Andrew John Hugh Macintyre (Chief Financial Officer) Buy 2,000 1.10 2,200
2021-11-02 Sims Andrew John Hugh Macintyre (Chief Financial Officer) Buy 1,000 1.86 1,864
2021-10-27 Petersen Greg (Director) Buy 12,500 1.72 21,500
2021-10-26 Sims Andrew John Hugh Macintyre (Chief Financial Officer) Buy 2,000 1.67 3,338
2021-10-26 Hedrick Marc H (Chief Executive Officer) Buy 2,500 1.66 4,150
2021-09-13 Lenk Robert P (Director) Buy 7,000 1.86 13,013
2021-07-28 Sims Andrew John Hugh Macintyre (Chief Financial Officer) Buy 2,244 1.91 4,286
2021-07-27 Sims Andrew John Hugh Macintyre (Chief Financial Officer) Buy 1,986 2.05 4,071
2021-04-30 Hedrick Marc H (Chief Executive Officer) Buy 2,183 2.28 4,970
2021-03-04 Hedrick Marc H (Chief Executive Officer) Buy 2,500 2.50 6,250
2021-03-03 Clowes Howard (Director) Buy 3,000 2.42 7,260
2020-12-10 Hedrick Marc H (Chief Executive Officer) Buy 2,500 1.99 4,975
2020-11-30 Hedrick Marc H (Chief Executive Officer) Buy 2,200 2.14 4,708
2020-08-25 Lenk Robert P (Director) Buy 3,000 2.49 7,464
2020-08-13 Petersen Greg (Director) Buy 10,000 2.80 28,000
2020-08-12 Petersen Greg (Director) Buy 10,000 2.52 25,200
2020-08-12 Hedrick Marc H (Chief Executive Officer) Buy 4,000 2.58 10,320
2020-06-22 Hedrick Marc H (Chief Executive Officer) Buy 5,000 2.10 10,500
2018-02-14 Postfinance Ag (10% Owner) Sale 473,831 .34 161,102
2018-02-09 Postfinance Ag (10% Owner) Sale 7,552 .34 2,567
2018-02-08 Postfinance Ag (10% Owner) Sale 228,603 .34 78,410
2018-01-11 Swissquote Bank Sa Sale 72,630 .34 24,694
2018-01-10 Swissquote Bank Sa Sale 15,796 .38 6,002
2018-01-09 Swissquote Bank Sa Sale 100,000 .38 38,300
2016-08-10 Harris John David (VP and GM Cell Therapy) Buy 2,500 2.03 5,074
2016-06-14 Naughton Gail K Buy 1,000 2.10 2,100
2016-06-14 Rickey David Buy 5,000 2.10 10,500
2016-03-09 Rickey David Buy 150,000 .19 28,350
2015-09-03 Thompson Tommy G Buy 25,449 .38 9,543
2015-09-02 Hayden Jeremy B. (General Counsel & VP of BD) Buy 8,200 .35 2,911
2015-08-28 Hedrick Marc H (President and CEO) Buy 1,200 .31 372
2015-08-28 Rickey David Buy 56,000 .32 17,640
2015-08-27 Hedrick Marc H (President and CEO) Buy 10,000 .30 3,050
2015-08-27 Rickey David Buy 50,000 .30 14,950
2015-08-26 Rickey David Buy 25,000 .33 8,175
2015-08-21 Hedrick Marc H (President and CEO) Buy 10,000 .36 3,650
2015-08-21 Rickey David Buy 50,000 .38 18,750
2015-08-20 Hedrick Marc H (President and CEO) Buy 10,000 .40 4,000
2015-08-19 Kesten Steven (Exec VP and Chief MO) Buy 6,000 .39 2,322
2015-08-19 Hayden Jeremy B. (General Counsel & VP of BD) Buy 18,000 .39 7,056
2015-08-19 Rickey David Buy 48,600 .39 19,099
2015-08-18 Girao Tiago (VP & Chief Financial Officer) Buy 25,000 .39 9,750
2015-08-18 Hedrick Marc H (President and CEO) Buy 10,000 .39 3,920
2015-08-18 Rickey David Buy 51,400 .39 20,200
2015-04-06 Lim Kian Thiam (10% Owner) Sale 600,000 1.37 822,600

Insider trading activities including stock purchases, stock sales, and option exercises of PSTV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Plus Therapeutics, Inc. (symbol PSTV, CIK number 1095981) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.